AbbVie Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (81)

Latest Posts

About This Stock More About This Stock
Biotech Rally Clipped By Trump Tweet; ACA Makeover Creates Uncertainty
Article By: Rod Raynovich
Wednesday, March 8, 2017 2:00 AM EDT
Just as investors were becoming more enthusiastic with biotechnology investing, a barrage of tweets and news stories regarding the ACA overhaul by Republicans cooled the market.
In this article: RHHBY, FBIOX, ALXN, ARRY, BMRN, IBB, REGN, ALKS, XBI, XLV, ICPT, ABBV, FMI, AUPH
Read
How To Indirectly Play The "Weed Rush"
Article By: Jennifer Coombs
Tuesday, February 28, 2017 5:54 AM EDT
I remain optimistic that the states will continue to see that the pros greatly outweigh the cons when it comes to the legalization of cannabis. There are some creative ways to indirectly benefit from the weed rush across the U.S.
In this article: PM, SMG, GWPH, ABBV
Read
Large Cap Biopharmaceuticals: Update On Financial Metrics
Article By: Rod Raynovich
Sunday, February 12, 2017 4:12 AM EDT
We have updated the comparison of eight large cap biopharma stocks post 2016 earnings for the period ending 2/10/17. Keep in mind that in January 2016 there was a severe correction with stocks dropping 25-30% with lows being hit in February 2016.
In this article: BMY, ALXN, AMGN, CELG, GILD, ABBV, IBB, REGN Also: XBI
Read
Biotech Stock Roundup: Celgene, Biogen, ABBV Posted Q4 Results, Catabasis Falls On DMD Data
Article By: Arpita Dutt
Thursday, February 2, 2017 8:56 AM EDT
Companies like Celgene, Biogen and AbbVie reported fourth quarter results last week. Catabasis suffered a major setback with its lead pipeline candidate edasalonexent failing to meet the primary endpoint.
In this article: REGN, XOMA, AMGN, BIIB, CELG, CATB, ABBV
Read
Large Cap Biopharma: January ’17 Update
Article By: Rod Raynovich
Tuesday, January 31, 2017 9:24 PM EDT
In this article, stock prices are compared for the one year bear market 1/7/16 - 1/31/17.
In this article: BMY, AMGN, CELG, GILD, XBI, ABBV Also: FBIOX, ALXN, IBB, REGN, BIIB, FBT
Read

PARTNER HEADLINES

Latest Tweets for $ABBV

No tweets yet!

$ABBV

AbbVie Inc. Increases Humira Prices, Receives FDA Approval For New Drug
Bruce Powers 1/23/2017 6:21:09 PM

Excited to hear the #FDA approved #IMBRUVICA. Should bode very well for $ABBV. And I think it's 8% price hike of #Humira is reasonable (though I realize those taking the drug may disagree).

1 to 1 of 1 comments